Gross Profit On Sales változás Dátum
Agios Pharmaceuticals USD 6.52M 249K 2023-12
ALKERMES USD 319.43M 234.71M 2023-09
Amgen USD 5.08B 14M 2023-12
Baxter International USD 1.49B 351M 2023-12
BioCryst Pharmaceuticals USD 85.61M 4.06M 2023-09
Biogen USD 1.77B 102.7M 2023-12
Bluebird Bio USD 1.44M 4.11M 2023-09
Bristol-Myers Squibb USD 8.77B 294M 2023-12
Cara Therapeutics USD 3.31M 2.21M 2023-09
Cipla INR 43.65B 2.73B 2023-09
Dr.Reddys Laboratories INR 49B 793M 2023-09
Eisai JPY 140.19B 12.82B 2023-09
Eli Lilly USD 7.57B 73.1M 2023-12
Esperion Therapeutics USD 20.59M 1.59M 2023-09
Exelixis USD 453.15M 1M 2023-09
Gilead Sciences USD 5.5B 18M 2023-12
GlaxoSmithKline GBP 5.91B 626M 2023-09
Grifols EUR 631.83M 13.37M 2023-09
Halozyme Therapeutics USD 177.74M 16.53M 2023-12
Incyte USD 949.29M 84.66M 2023-12
Ionis Pharmaceuticals USD 321.44M 179.43M 2023-12
Ironwood Pharmaceuticals USD 117.13M 13.38M 2021-12
Merck USD 11.29B 441M 2023-12
Nektar Therapeutics USD 11.71M 1.79M 2023-09
Neurocrine Biosciences USD 487.6M 46.4M 2023-09
Pfizer USD 7.58B 3.26B 2023-12
Roche Holding CHF 22.16B 123M 2023-06
Sarepta Therapeutics USD 294.79M 67.68M 2023-09
Takeda JPY 699.51B 38B 2023-09
Teva Pharmaceutical Industries USD 1.9B 20M 2023-09



Nektar Therapeutics Bruttó Nyereség Az Eladási - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2024.